WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Adam J. Cole
Associate
Patents and Innovations
San Francisco
acole@wsgr.com

D650-849-3298

Download vCard
Open PDF

Dr. Adam Cole is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati.

Adam’s practice focuses on strategic intellectual property counseling in a variety of technical areas, including genomics, nucleic acid sequencing, molecular diagnostics, materials science, engineering, and other life science and biotechnological arts. He prosecutes patents both in the United States and internationally and conducts patent diligence, including the evaluation of patent portfolios and engaging in freedom-to-operate analyses.

Adam started with the firm as a scientific advisor in 2012, rose to senior patent agent, and transitioned to associate in 2019 after participating in the firm’s law-school work-study program for patent agents. Prior to joining the firm, Adam was a postdoctoral fellow at Stanford University, where he studied novel nanomaterials as contrast agents in the early detection of cancer through the use of multi-modality molecular imaging. Adam’s doctoral work at the University of Michigan College of Pharmacy focused on improving the delivery of magnetically targeted, therapeutic iron oxide nanoparticles to brain tumors.

Adam also teaches Patent Prosecution and the IP Practicum Clinic at UC Berkeley School of Law and is part of UC Berkeley Bakar Labs' Advisory Group.

Experience

Dr. Adam Cole is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati.

Adam’s practice focuses on strategic intellectual property counseling in a variety of technical areas, including genomics, nucleic acid sequencing, molecular diagnostics, materials science, engineering, and other life science and biotechnological arts. He prosecutes patents both in the United States and internationally and conducts patent diligence, including the evaluation of patent portfolios and engaging in freedom-to-operate analyses.

Adam started with the firm as a scientific advisor in 2012, rose to senior patent agent, and transitioned to associate in 2019 after participating in the firm’s law-school work-study program for patent agents. Prior to joining the firm, Adam was a postdoctoral fellow at Stanford University, where he studied novel nanomaterials as contrast agents in the early detection of cancer through the use of multi-modality molecular imaging. Adam’s doctoral work at the University of Michigan College of Pharmacy focused on improving the delivery of magnetically targeted, therapeutic iron oxide nanoparticles to brain tumors.

Adam also teaches Patent Prosecution and the IP Practicum Clinic at UC Berkeley School of Law and is part of UC Berkeley Bakar Labs' Advisory Group.

Education
  • J.D., UC Berkeley School of Law, 2019
  • Postdoctoral Fellowship, Molecular Imaging, Stanford University, 2012
  • Ph.D., Pharmaceutical Sciences, University of Michigan, 2011American Foundation for Pharmaceutical Education National Predoctoral Fellowship, 2008-2011; President, Rackham Student Government; Co-founder, Student Advocates for Graduate Education (SAGE)
  • M.S., Pharmaceutical Sciences, University of Michigan, 2007
  • B.S.E., Chemical Engineering, University of Michigan, 2004Summa Cum Laude; Member, Tau Beta Pi National Engineering Honor Society; Member, Omega Chi Epsilon National Chemical Engineering Honor Society
Associations and Memberships
  • Member, UC Berkeley Bakar Labs Advisory Group
Admissions
  • U.S. Patent and Trademark Office
  • State Bar of California
Credentials
Education
  • J.D., UC Berkeley School of Law, 2019
  • Postdoctoral Fellowship, Molecular Imaging, Stanford University, 2012
  • Ph.D., Pharmaceutical Sciences, University of Michigan, 2011American Foundation for Pharmaceutical Education National Predoctoral Fellowship, 2008-2011; President, Rackham Student Government; Co-founder, Student Advocates for Graduate Education (SAGE)
  • M.S., Pharmaceutical Sciences, University of Michigan, 2007
  • B.S.E., Chemical Engineering, University of Michigan, 2004Summa Cum Laude; Member, Tau Beta Pi National Engineering Honor Society; Member, Omega Chi Epsilon National Chemical Engineering Honor Society
Associations and Memberships
  • Member, UC Berkeley Bakar Labs Advisory Group
Admissions
  • U.S. Patent and Trademark Office
  • State Bar of California

Select Life Sciences Work

  • 10X Genomics in intellectual property matters
Matters

Select Life Sciences Work

  • 10X Genomics in intellectual property matters

Select Publications

  • Co-author with J. Jokerst, D. Van de Sompel, and S. Gambhir, "Gold Nanorods for Ovarian Cancer Detection with Photoacoustic Imaging and Resection Guidance via Raman Imaging in Living Mice," 6 ACS Nano 10366-77, 2012
  • Co-author with L. Han, Y. Fu, J. Liu, and J. Wang, "Co-encapsulation and Sustained-Release of Four Components in Gingko Terpenes from Injectable PELGE Nanoparticles," 83 Fitoterapia 721-731, 2012
  • Co-author with A. David and V. Yang, "Magnetically Targeted Nanoparticles for Brain Tumor Therapy: What Does the Future Hold?" 6 Nanomedicine 1133-1135, 2011
  • Co-author with A. David, J. Wang, C. Galbán, and V. Yang, "Magnetic Brain Tumor Targeting and Biodistribution of Long-Circulating PEG-Modified, Cross-Linked Starch Coated Iron Oxide Nanoparticles," 32 Biomaterials 6291-6301, 2011
  • Co-author with V. Yang and A. David, "Cancer Theranostics: The Rise of Targeted Magnetic Nanoparticles," 29 Trends in Biotechnology 323-332, 2011
  • Co-author with A. David, B. Chertok, and V. Yang, "A Combined Theoretical and In Vitro Modeling Approach for Predicting the Magnetic Capture and Retention of Magnetic Nanoparticles In Vivo," 152 Journal of Controlled Release 67-75, 2011
  • Co-author with A. David, J. Wang, C. Galbán, H. Hill, and V. Yang, "Polyethylene Glycol Modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting," 32 Biomaterials 2183-2193, 2011
  • Co-author with B. Chertok, A. David, and V. Yang, "Comparison of Electron Spin Resonance Spectroscopy and Inductively Coupled Plasma Optical Emission Spectroscopy for Biodistribution Analysis of Iron-Oxide Nanoparticles," 7 Molecular Pharmaceutics 375-385, 2010
  • Co-author with L. Zhang, F. Yu, B. Chertok, A. David, J. Wang, and V. Yang, "Gum Arabic-Coated Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor Imaging," 11 AAPS Journal 693-699, 2009
  • Co-author with F. Yu, Y. Huang, and V. Yang, "The Artificial Peroxidase Activity of Magnetic Iron Oxide Nanoparticles and Its Application to Glucose Detection," 30 Biomaterials 4716-4722, 2009
Insights

Select Publications

  • Co-author with J. Jokerst, D. Van de Sompel, and S. Gambhir, "Gold Nanorods for Ovarian Cancer Detection with Photoacoustic Imaging and Resection Guidance via Raman Imaging in Living Mice," 6 ACS Nano 10366-77, 2012
  • Co-author with L. Han, Y. Fu, J. Liu, and J. Wang, "Co-encapsulation and Sustained-Release of Four Components in Gingko Terpenes from Injectable PELGE Nanoparticles," 83 Fitoterapia 721-731, 2012
  • Co-author with A. David and V. Yang, "Magnetically Targeted Nanoparticles for Brain Tumor Therapy: What Does the Future Hold?" 6 Nanomedicine 1133-1135, 2011
  • Co-author with A. David, J. Wang, C. Galbán, and V. Yang, "Magnetic Brain Tumor Targeting and Biodistribution of Long-Circulating PEG-Modified, Cross-Linked Starch Coated Iron Oxide Nanoparticles," 32 Biomaterials 6291-6301, 2011
  • Co-author with V. Yang and A. David, "Cancer Theranostics: The Rise of Targeted Magnetic Nanoparticles," 29 Trends in Biotechnology 323-332, 2011
  • Co-author with A. David, B. Chertok, and V. Yang, "A Combined Theoretical and In Vitro Modeling Approach for Predicting the Magnetic Capture and Retention of Magnetic Nanoparticles In Vivo," 152 Journal of Controlled Release 67-75, 2011
  • Co-author with A. David, J. Wang, C. Galbán, H. Hill, and V. Yang, "Polyethylene Glycol Modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting," 32 Biomaterials 2183-2193, 2011
  • Co-author with B. Chertok, A. David, and V. Yang, "Comparison of Electron Spin Resonance Spectroscopy and Inductively Coupled Plasma Optical Emission Spectroscopy for Biodistribution Analysis of Iron-Oxide Nanoparticles," 7 Molecular Pharmaceutics 375-385, 2010
  • Co-author with L. Zhang, F. Yu, B. Chertok, A. David, J. Wang, and V. Yang, "Gum Arabic-Coated Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor Imaging," 11 AAPS Journal 693-699, 2009
  • Co-author with F. Yu, Y. Huang, and V. Yang, "The Artificial Peroxidase Activity of Magnetic Iron Oxide Nanoparticles and Its Application to Glucose Detection," 30 Biomaterials 4716-4722, 2009

Biological Sciences and Biotechnology

  • Biochemical assays
  • Biochemistry
  • Bioconjugation
  • Cancer therapeutics
  • CAR-T cells
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Epigenetics
  • Genetics
  • Genomics
  • Metabolomics
  • Microbiology
  • MicroRNA (miRNA) research
  • Molecular biology
  • Molecular genetics
  • PCR
  • Proteomics

Therapeutics and Drug Discovery

  • Drug delivery
  • Gene editing
  • Gene therapy
  • Pharmacokinetics
  • RNA interference (RNAi)

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Medical devices
  • Medical imaging
  • Neuroimaging
  • Point-of-care testing (POCT)
  • Wearable analyte sensors

Chemistry and Material Science

  • Chemistry
  • Materials chemistry
  • Nanochemistry
  • Photovoltaic materials
  • Polymers
  • Process chemistry
  • Protein engineering

Engineering and Technology

  • Materials science
  • Microfluidics

Genomics and Data Analysis

  • Functional genomics
  • Next-generation sequencing
  • rDNA
  • Sequencing
  • shRNA
  • Single-cell sequencing

Miscellaneous

  • Engineered foods
  • Food science
  • Formulations
Technical Fluency

Biological Sciences and Biotechnology

  • Biochemical assays
  • Biochemistry
  • Bioconjugation
  • Cancer therapeutics
  • CAR-T cells
  • Cell biology
  • Cell culture products
  • Cell therapy
  • Cellular biology
  • Epigenetics
  • Genetics
  • Genomics
  • Metabolomics
  • Microbiology
  • MicroRNA (miRNA) research
  • Molecular biology
  • Molecular genetics
  • PCR
  • Proteomics

Therapeutics and Drug Discovery

  • Drug delivery
  • Gene editing
  • Gene therapy
  • Pharmacokinetics
  • RNA interference (RNAi)

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Medical devices
  • Medical imaging
  • Neuroimaging
  • Point-of-care testing (POCT)
  • Wearable analyte sensors

Chemistry and Material Science

  • Chemistry
  • Materials chemistry
  • Nanochemistry
  • Photovoltaic materials
  • Polymers
  • Process chemistry
  • Protein engineering

Engineering and Technology

  • Materials science
  • Microfluidics

Genomics and Data Analysis

  • Functional genomics
  • Next-generation sequencing
  • rDNA
  • Sequencing
  • shRNA
  • Single-cell sequencing

Miscellaneous

  • Engineered foods
  • Food science
  • Formulations
Focus Areas
  • Diagnostics, Life Science Tools, and Deep Tech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Aqtual on $31 Million Series B
On July 10, 2025, Aqtual, a Hayward, California-based precision medicine company, announced the closing of its $31 million Series B financing round. Investors in the oversubscribed round included Bold Capital, the Bold Longevity Growth Fund, Genoa Ventures, Manta Ray Ventures, Yu Galaxy, and others. Wilson Sonsini Goodrich & Rosati advised Aqtual on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Genoa Ventures on Patent Matters Related to AlidaBio’s $7.5 Million Series A
On June 12, 2024, Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, announced it has completed a $7.5 million Series A financing. Genoa Ventures led the funding round with participation from FusionX Ventures and Vertical Venture Partners and is complemented by two ongoing Small Business Innovation Research grants of $4 million from The National Human Genome Research Institute. Wilson Sonsini Goodrich & Rosati advised Genoa Ventures on patent matters related to the transaction.
Learn More
View All
Recent Events
Affiliated Programs
How Does a Company Manage Its Intellectual Property Estate?: Perspectives From In-House Counsels
Even in the earliest stages, generating and securing intellectual property is a critical component of a company’s business plan. Many early-stage companies rely on outside counsel to do the heavy lifting, but what should be done (or not done) internally with respect to IP? What can a company do to help maximize its relationship with outside counsel, while keeping a realistic budget? How can a company best manage its research and develop teams to capture IP? When is it time to start building an internal IP team? What can be done internally to help prepare for a financing? Where can things go wrong? Here’s your chance to learn from the best: Join our August 28 panel with Randy Wu of 10x Genomics, Yina Dong of Veracyte, Rachel Herder of Mammoth Biosciences and Aric Ledford of Freenome, moderated by Ali Alemozafar and Adam Cole of Wilson Sonsini Goodrich & Rosati.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.